SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.17847452 USD and is down -3.32 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,362,443,159.56 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline and relative underperformance are driving discussion, with traders pointing to broader crypto weakness and worries that political gridlock could delay the Clarity Act. The community is split between sellers citing weak utility, Ripples token supply and a lack of follow-through on positive developments, and holders treating the dip as a buying opportunity.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Healths strong Q3 results and another increase to its full-year operating outlook are the main focus, but shares have sold off despite the positive report. Bulls see improving profitability and execution, while skeptics question how durable the results are and point to risk-adjustment exposure, claims costs and profit-taking as possible concerns.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs Q3 results and restructuring are the main focus: traders cite a revenue and EPS miss, weaker Crysvita sales tied to ordering patterns, and a roughly 20% headcount reduction alongside the reaffirmed 2027 profitability goal. Reactions are mixed, with disappointment over the report and pipeline setbacks offset by support for deeper cost cuts and confidence in the newly approved therapies potential.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Falling lithium spot and futures prices are weighing on Albemarle, with traders debating whether the selloff has reached a bottom and some waiting to add while others expect further downside. Bulls argue that longer-term EV and energy-storage demand remains intact, but the near-term outlook is seen as closely tied to lithium pricing and earnings guidance.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charters third-quarter results are drawing attention as broadband customer losses, declining pro forma revenue and a large franchise impairment fuel concerns about the business and Cox deal. Some traders remain optimistic about planned cost savings, Cox synergies and mobile growth, while others doubt those gains will offset subscriber attrition and debt concerns.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

AXON is selling off after a Q3 miss and a cut to its full-year outlook, with the company attributing part of the pressure to delayed federal Dedrone counter-drone deployments. Traders debate whether the drop is an overreaction and a buying opportunity or a repricing justified by high valuation, margin pressure, and stock-based compensation concerns.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports large stock-and-convertible offering is driving discussion, as traders weigh dilution against funding for RAP-219s planned Phase 3 trials. Insider purchases and positive Phase 2 bipolar-mania results support the bullish view, while skeptics point to dilution and the studys modest efficacy signal.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSparks sharp selloff and underperformance versus Bitcoin have traders debating whether its AI/data-center pivot can deliver amid Texas permitting uncertainty and concerns about financing and execution. The recent bounce has drawn dip-buyers and short-squeeze speculation, while skeptics remain focused on the risks and managements track record.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgents CFO departure triggered a steep selloff and speculation about possible financial problems; the company said the exit was not related to disagreements and indicated quarterly revenue and adjusted EBITDA would exceed prior guidance. Traders are split between calling the decline an overreaction and buying on the companys backlog and data-center power exposure, versus waiting for further clarity.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes strong Q3 results have not eased concern about its steep selloff: traders are debating whether Auvelitys Alzheimers-agitation launch is ramping too slowly and whether high costs and the lack of specific profitability guidance will delay operating leverage. Some see the reaction as overdone given ongoing prescription growth and the pipeline, while others want clearer evidence of launch progress.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
